Promising results from a small study may offer hope for the treatment of multiple sclerosis (MS).
Researchers from the University of California – San Diego report dramatic improvement after treating MS patients with stromal vascular fraction (SVF) stem cells from a patient’s own body fat. They say the SVF therapy can limit the body’s immune system reaction and promote the growth of new myelin – the fatty “insulation” on axons in the brain, which breaks down in patients with MS.
“None of the presently available MS treatments selectively inhibit the immune attack against the nervous system, nor do they stimulate regeneration of previously damaged tissue,” Boris Minev, M.D., from the Division of Neurosurgery at UCSD, was quoted as saying. “We’ve shown that SVF cells may fill this therapeutic gap”.
Only three patients were treated in the study, but all three showed dramatic results following treatment, including improved balance and coordination and increased energy. They also say their frequent, painful seizures had stopped.